Amrith Kumar

Amrith Kumar is a technologist and entrepreneur who has helped design, architect and create enterprise class software and hardware products. He is the co-founder of the Boston Big Data Summit and writes a blog, Hype Cycles, which discusses a variety of technology related subjects.

Recent posts

A Report from Boston’s First “Big Data Summit”
The first meeting of the Boston Big Data Summit was held yesterday. Since the announcement on October 2, the event has had a great reception. Just over a hundred people attended,... Read more »
Legislators Hear Testimony on Non-Compete Restrictions
Today marked a milestone in the legislation relating to non-competes in Massachusetts. The Joint Committee on Labor and Workforce Development held its public hearing on two house bills that would attempt... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

AbCellera Raises $105M to Advance Antibody Discovery Operations

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

Unlearn Adds $12M for “Digital Twins” That Accelerate Clinical Trials

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Amrith Kumar

Recent posts

A Report from Boston’s First “Big Data Summit”

Legislators Hear Testimony on Non-Compete Restrictions

Underwriters and Partners

How to Approach Life Sciences Fundraising

Containing Coronavirus Through Innovation and Investment

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

Xconomy on Demand

We offer a number of ways to subscribe for free!